Extensive HCP Access and Research Coverage Across Alzheimer’s, Multiple Sclerosis, Epilepsy, Parkinson’s, and Other Neurological Disorders
Konovo’s Neurology Therapeutic Breakdown delivers a comprehensive view of global market research capabilities in neurological care, with coverage across the Americas, Europe, and Asia. Over the last three years, we have completed 810 projects and collected 55,722 respondent completes from a verified panel of over 2 million healthcare professionals, including neurologists, epileptologists, neurosurgeons, movement disorder specialists, nurse practitioners, and physician assistants. Our research spans key conditions such as Alzheimer’s disease, chronic migraine, epilepsy, multiple sclerosis, Parkinson’s disease, spinal muscular atrophy, stroke, and Wilson’s disease. Supported by proprietary technologies and rigorous quality controls, Konovo ensures accurate, representative data to help pharmaceutical, biotech, and medtech companies make faster, evidence-based decisions in the evolving neurology market.
